IGF-1 promotes cellular growth, tissue repair, and muscle hypertrophy, while LR3, a longer-acting variant, increases the peptides bioavailability and prolongs its effects
Studies demonstrate BPC-157 increases angiogenesis by 129-152% compared to controls
Long-term treatment of growth hormone insensitivity syndrome with IGF-I
Laboratory specialists have investigated its relationship with structural proteins, signaling molecules, and gene regulatory pathways that contribute to tissue maintenance and adaptation
The foundational obesity finding comes from Kraus and colleagues (Nature, 2014), who showed that knocking down NNMT protected mice against diet-induced obesity establishing NNMT as a metabolic target in the first place
Pie charts were created by using chiplot online software (Perez-Riverol et al., 2025) partner repository with the dataset identifier PXD065550